{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:49:33Z","timestamp":1762897773738,"version":"3.43.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1019533806868","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T18:25:54Z","timestamp":1047579954000},"page":"469-472","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of cystocopically pseudotumoral lesions (inflammation\/granuloma) in primary stage T1 grade 3 bladder tumors treated with BCG"],"prefix":"10.1007","volume":"33","author":[{"given":"E.","family":"Pieras-Ayala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Palou-Redorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.I.","family":"Tornero-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Montlle\u00f3-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Salvador-Bayarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vicente-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"395815_CR1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0022-5347(17)40002-4","volume":"143","author":"JA. Mart\u00ednez Pi\u00f1eiro","year":"1990","unstructured":"Mart\u00ednez Pi\u00f1eiro JA. Bacillus Calmette-G\u00fcerin versus doxor-ubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. J Urol 1990; 143: 502","journal-title":"J Urol"},{"key":"395815_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","volume":"163","author":"F Mill\u00e1n","year":"2000","unstructured":"Mill\u00e1n F, Ch\u00e9chile G, Salvador J et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 73","journal-title":"J Urol"},{"issue":"1","key":"395815_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000020090","volume":"37","author":"A. B\u00f6hle","year":"2000","unstructured":"B\u00f6hle A. For the EBIN group. BCG's mechanism of action-increasing our understanding. Eur Urol 2000; 37(suppl 1): 1","journal-title":"Eur Urol"},{"key":"395815_CR4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-410X.1987.tb05039.x","volume":"60","author":"MI El-Demiry","year":"1987","unstructured":"El-Demiry MI, Smith G, Ritchie WS et al. Local inmune responses after BCG treatment for carcinoma in situ. Br J Urol 1987; 60: 543","journal-title":"Br J Urol"},{"issue":"3","key":"395815_CR5","first-page":"211","volume":"54","author":"E Pieras","year":"2001","unstructured":"Pieras E, Palou J, Rodr\u00edguez-Villamil L et al. Seguimiento cistosc\u00f3pico de los tumors vesicales G3T1 iniciales tratados con BCG. Arch Esp Urol 2001; 54(3): 211","journal-title":"Arch Esp Urol"},{"key":"395815_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00326845","volume":"6","author":"A Shapiro","year":"1988","unstructured":"Shapiro A, Lijovetz G, Pode D. Changes of the mucosal archi-tecture and of urine cytology during BCG treatment. World J Urol 1988; 6: 61","journal-title":"World J Urol"},{"key":"395815_CR7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-5347(17)41803-9","volume":"140","author":"RD Oates","year":"1988","unstructured":"Oates RD, Stilmant MM, Freedlund MC, Siroky MB. Granu-lomatous prostatitis following Bacillus Calmette Gu\u00e9rin immunotherapy of bladder cancer. J Urol 1988; 140: 751","journal-title":"J Urol"},{"key":"395815_CR8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0022-5347(17)39752-5","volume":"144","author":"E Mukamel","year":"1990","unstructured":"Mukamel E, Konichezky M, Engelstein D et al. Clinical and pathologycal findings in prostates following intravesical Bacillus Calmette Gu\u00e9rin instillations. J Urol 1990; 144: 1399","journal-title":"J Urol"},{"key":"395815_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00299721","volume":"20","author":"JS Teppema","year":"1992","unstructured":"Teppema JS, De Boer EC, Steerenberg PA, Van Der Meijden APM. Morphological aspects of the interaction of Bacillus Calmette Gu\u00e9rin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity? Urol Res 1992; 20: 219\u2013228","journal-title":"Urol Res"},{"key":"395815_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-5347(01)66424-3","volume":"155","author":"TM De Reijke","year":"1996","unstructured":"De Reijke TM, De Boer EC, Hein Kurth K, Schamhart DHJ. Urinary Cytokines during intravesical Bacillus Calmette Gu\u00e9rin therapy for superficial bladder cancer: processing, stability and prognostic value. J Urol 1996; 155: 477","journal-title":"J Urol"},{"key":"395815_CR11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)66983-2","volume":"164","author":"GN Thalmann","year":"2000","unstructured":"Thalmann GN, Sermier A, Rentsch C et al. Urinary interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with Bacillus Calmette Gu\u00e9rin. J Urol 2000; 164: 2129","journal-title":"J Urol"},{"key":"395815_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0090-4295(92)90523-Y","volume":"40","author":"P Bassi","year":"1992","unstructured":"Bassi P, Milani C, Meneghini A et al. Clinical value of patho-logic changes after intravesical BCG therapy of superficial bladder cancer. Urology 1992; 40: 175","journal-title":"Urology"},{"key":"395815_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette Gu\u00e9rin in the treatment of superficial bladder tumors. J Urol 1976; 116: 180","journal-title":"J Urol"},{"issue":"2","key":"395815_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0090-4295(85)90525-4","volume":"25","author":"HW Herr","year":"1985","unstructured":"Herr HW, Pinsky CM, Whitmores WF et al. Experience with intravesical Bacillus Calmette Gu\u00e9rin therapy of superficial bladder tumors. Urology 1985; 25(2): 119","journal-title":"Urology"},{"key":"395815_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-5347(17)45603-5","volume":"135","author":"PF Schellhammer","year":"1986","unstructured":"Schellhammer PF, Ladaga LE, Fillion MB. Bacillus Calmette Gu\u00e9rin for superficial transitional cell carcinoma of the bladder. J Urol 1986; 135: 261","journal-title":"J Urol"},{"key":"395815_CR16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-5347(17)45605-9","volume":"135","author":"DR Kelley","year":"1986","unstructured":"Kelley DR, Haaff EO, Becich M et al. Prognostic value of purified derivate skin test and granuloma formation in patients treated with intravesical Bacillus Calmette Gu\u00e9rin. J Urol 1986; 135: 268","journal-title":"J Urol"},{"key":"395815_CR17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-5347(17)42723-6","volume":"139","author":"RJ Torrence","year":"1988","unstructured":"Torrence RJ, Kavoussi LR, Catalona WJ, Ratliff TL.Prognostic factors in patients treated with intravesical Bacillus Calmette Gu\u00e9rin for superficial bladder cancer. J Urol 1988; 139: 941","journal-title":"J Urol"},{"key":"395815_CR18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1464-410X.1995.tb07309.x","volume":"75","author":"L Bowyer","year":"1995","unstructured":"Bowyer L, Hall RR, Reading J, Marsch MM. The persistence of bacille Calmette Gu\u00e9rin in the bladder after intravesical treatment for bladder cancer. Br J Urol 1995; 75: 188","journal-title":"Br J Urol"},{"issue":"1","key":"395815_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000052376","volume":"37","author":"DL. Lamm","year":"2000","unstructured":"Lamm DL. Preventing progression and improving survival with BCG maintenance. Eur Urol 2000; 37(suppl 1): 9","journal-title":"Eur Urol"},{"key":"395815_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-5347(17)43864-X","volume":"137","author":"G Jackse","year":"1987","unstructured":"Jackse G, Loidl W, Seeber G, Hofst\u00e4dter F. Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?J Urol 1987; 137: 39","journal-title":"J Urol"},{"key":"395815_CR21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-5347(17)40575-1","volume":"141","author":"HW Herr","year":"1989","unstructured":"Herr HW, Badalament RA, Amato DA et al. Superficial bladder cancer treated with Bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J Urol 1989; 141: 22","journal-title":"J Urol"},{"key":"395815_CR22","first-page":"3","volume":"86","author":"J Palou","year":"2000","unstructured":"Palou J, Rosales A, Mill\u00e1n F et al. Clinical prognostic factors of recurrence and progression in TCC stage T1G3 treated with BCG. B J U Int 2000; 86(Suppl 3): 3","journal-title":"B J U Int"},{"key":"395815_CR23","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0022-5347(01)65458-2","volume":"156","author":"R Hurle","year":"1996","unstructured":"Hurle R, Losa A, Ranieri A et al. Low dose Pasteur Bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapy. J Urol 1996; 156: 1602","journal-title":"J Urol"},{"key":"395815_CR24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","volume":"54","author":"R Hurle","year":"1999","unstructured":"Hurle R, Losa A, Manzetti A, Lembo A. Intravesical Bacille Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: a 7-year follow-up. Urology 1999; 54: 258","journal-title":"Urology"},{"key":"395815_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000019664","volume":"34","author":"T Lebret","year":"1998","unstructured":"Lebret T, Gaudez F, Herv\u00e9 JM et al. Low-Dose BCG instilla-tions in the treatment of Stage T1 grade 3 bladder tumors: recurrence, progression and success. Eur Urol 1998; 34: 67","journal-title":"Eur Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019533806868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1019533806868\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019533806868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T06:02:58Z","timestamp":1754892178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1019533806868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["395815"],"URL":"https:\/\/doi.org\/10.1023\/a:1019533806868","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}